Clinical trials
Withdrawn Glioma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| NYU Langone Health | 2 |
| University of Michigan Rogel Cancer Center | 2 |
| Annick Desjardins | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Constantinos Hadjipanayis | 1 |
| Dana-Farber Cancer Institute | 1 |
| Duke University | 1 |
| INSYS Therapeutics Inc | 1 |
| InSightec | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 27 |
| Glioblastoma | 15 |
| Astrocytoma | 8 |
| Brain Neoplasms | 7 |
| Ependymoma | 3 |
| Medulloblastoma | 3 |
| Meningioma | 3 |
| Oligodendroglioma | 3 |
| Diffuse Intrinsic Pontine Glioma | 2 |
| Gliosarcoma | 2 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.